Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+T Cell Response
Journal of Immunology - United States
doi 10.4049/jimmunol.1700467
Full Text
Open PDFAbstract
Available in full text
Date
April 11, 2018
Authors
Publisher
The American Association of Immunologists